Oncology Recommendations

To view Article Recommendations, you must have an active subscription.

If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.

If you think you should be able to access this content, please contact us.

New to F1000? See this week’s top article below for a free preview of a Recommendation.

Take the tour.

HEADS OF FACULTY

George Canellos

Department of Medical Oncology/Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA, USA
Bob Pinedo

Department of Medical Oncology, Vrije Universiteit, Amsterdam, Netherlands

LATEST RECOMMENDATION

This is an interesting phase II trial with a ‘no chemo’ regimen in relapsing non-Hodgkin lymphoma (NHL), but needs to be confirmed by randomized trials. The merit here could be to serve as...

Nicolas Mounier, Hôpital l'Archet, France. F1000 Hematology

Score:

Past 7 Days

New Recommendations

9,807 total

New Articles Recommended

5,888 total

Past 30 Days

23

Articles Classified As Controversial

612 total
9

Articles Classified As Novel Drug Target

327 total
1

Articles Classified As Changes Clinical Practice

374 total
4

Articles Classified As Review / Commentary

448 total
35

Articles Classified As Confirmation

2,281 total
8

Articles Classified As Technical Advance

574 total
53

Articles Classified As New Finding

4,720 total
16

Articles Classified As Interesting Hypothesis

1,150 total
25

Articles Classified As Good for Teaching

264 total
40

Articles Classified As Clinical Trial

3,100 total

INDIVIDUAL SUBSCRIPTIONS

Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.

Start your personal subscription today.

Subscribe for $9.95/month

Take the tour.